Cutler Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$3K 4341
2022
Q3
$3K Sell
200
-7,800
-98% -$131K ﹤0.01% 3899
2022
Q2
$92K Sell
8,000
-6,500
-45% -$128K 0.01% 1493
2022
Q1
$116K Buy
14,500
+9,600
+196% +$245K 0.01% 1585
2021
Q4
$45K Buy
4,900
+3,300
+206% +$134K ﹤0.01% 2474
2021
Q3
$5K Sell
1,600
-400
-20% -$17.9K ﹤0.01% 4408
2021
Q2
$36K Sell
2,000
-1,000
-33% -$33.9K ﹤0.01% 2761
2021
Q1
$64K Sell
3,000
-16,100
-84% -$960K ﹤0.01% 2140
2020
Q4
$375K Sell
19,100
-3,600
-16% -$244K 0.02% 764
2020
Q3
$121K Sell
22,700
-2,500
-10% -$124K 0.01% 1204
2020
Q2
$135K Buy
25,200
+24,100
+2,191% +$831K 0.01% 1105
2020
Q1
$7K Buy
+1,100
New +$14.1K ﹤0.01% 2883
2017
Q1
Sell
-4,129
Closed -$150K 6322
2016
Q4
$150K Sell
4,129
-1,428
-26% -$21.3K 0.01% 1549
2016
Q3
$174K Buy
+5,557
New +$180K 0.01% 1333
2016
Q2
Sell
-186
Closed -$4K 6592
2016
Q1
$4K Sell
186
-343
-65% -$11.6K ﹤0.01% 4992
2015
Q4
$4K Buy
+529
New +$23.8K ﹤0.01% 5036

Other funds holding ARCT